AnalysisNews

MBIO today

$0.35-$0.02 (-4.30%)close Nov 20, 2026

Trend

DailyDowntrend (confirmed)

4 hourAscending Triangle

1 hourStrong Bearish

15 minStrong Bearish

5 minStrong Bullish

Daily trend turns up above $0.56

Key levels

Resistance$0.49

Resistance$0.43

Support$0.35

Latest news & SEC filings

ProductMindBio Therapeutics hits product development milestone, announces private placement

EarningsMustang Bio Posts Q3 2026 Financials

All MBIO news →

About Mustang Bio

Mustang Bio develops experimental treatments for hard-to-treat cancers, working at the clinical testing stage. Its programs center on engineered immune cells and modified viruses aimed at solid tumors, including aggressive brain cancers such as glioblastoma and high-grade astrocytoma. The company licenses these candidates from research centers including City of Hope and Nationwide Children's Hospital, and it is mostly owned by Fortress Biotech.

Based on the company's 10-K filed Mar 19, 2026.

Nasdaq · Healthcare

MUSTANG BIO, INC. (MBIO)

$0.35-0.02 (-4.30%)
HOLDGrade: DRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
0.380.400.420.440.35Oct 20Oct 28Nov 5Nov 13
High0.38
Low0.35
Open0.37
Volume25K
Avg Vol34K
VWAP0.36
30d High0.46
30d Low0.35
30d Chg-14.14%

What Is the Price Target for MBIO?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.38Upside: +0.0%Confidence: 20%Method: No Coverage

Is MBIO a Buy or Sell Right Now?

32
Investability Score
HOLD12-18 months

Test your own strategy on MBIO

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on MBIO with SEPT’s own market data.

Start Free Trial →

Is MBIO Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B

Fair Value

$2.40

7

Moat Score

NONE

3/9

Piotroski Score

-31.4

Altman Z-Score

What Is Smart Money Doing with MBIO?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

MBIO Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

98.99%

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for MBIO

PREVIEW

Recent off-exchange (dark pool) prints for MBIO: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
22:03:28$0.304,983$$1KBUY
22:03:18$0.294,876$$1KBUY
22:03:00$0.294,983$$1KBUY
21:46:38$0.305,000$$1KBUY
21:28:22$0.291,700$$500SELL

5 dark pool trades shown · $$6K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for MUSTANG BIO, INC. (MBIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

MBIO — frequently asked questions

What is MBIO stock price today?

MUSTANG BIO, INC. (MBIO) is at $0.35, down 4.30% (-$0.02) at the Nov 20, 2026 close.

Why is MBIO stock moving today?

Latest MBIO news — Nov 16, 2026: MindBio Therapeutics hits product development milestone, announces private placement · Nov 7, 2026: Mustang Bio Posts Q3 2026 Financials

Did MBIO beat earnings?

MBIO last reported on Aug 5, 2026: EPS -$0.16 vs -$140.00 expected — a beat of 99.9%.

What are MBIO support and resistance levels?

Support: $0.35. Resistance: $0.43, $0.49, $0.56.

What are insiders doing with MBIO?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on MBIO?

Nov 16, 2026: MindBio Therapeutics hits product development milestone, announces private placement · Nov 7, 2026: Mustang Bio Posts Q3 2026 Financials